cAMP signaling primes lung endothelial cells to activate caspase-1 during Pseudomonas aeruginosa infection

Am J Physiol Lung Cell Mol Physiol. 2020 May 1;318(5):L1074-L1083. doi: 10.1152/ajplung.00185.2019. Epub 2020 Mar 18.

Abstract

Activation of the inflammasome-caspase-1 axis in lung endothelial cells is emerging as a novel arm of the innate immune response to pneumonia and sepsis caused by Pseudomonas aeruginosa. Increased levels of circulating autacoids are hallmarks of pneumonia and sepsis and induce physiological responses via cAMP signaling in targeted cells. However, it is unknown whether cAMP affects other functions, such as P. aeruginosa-induced caspase-1 activation. Herein, we describe the effects of cAMP signaling on caspase-1 activation using a single cell flow cytometry-based assay. P. aeruginosa infection of cultured lung endothelial cells caused caspase-1 activation in a distinct population of cells. Unexpectedly, pharmacological cAMP elevation increased the total number of lung endothelial cells with activated caspase-1. Interestingly, addition of cAMP agonists augmented P. aeruginosa infection of lung endothelial cells as a partial explanation underlying cAMP priming of caspase-1 activation. The cAMP effect(s) appeared to function as a priming signal because addition of cAMP agonists was required either before or early during the onset of infection. However, absolute cAMP levels measured by ELISA were not predictive of cAMP-priming effects. Importantly, inhibition of de novo cAMP synthesis decreased the number of lung endothelial cells with activated caspase-1 during infection. Collectively, our data suggest that lung endothelial cells rely on cAMP signaling to prime caspase-1 activation during P. aeruginosa infection.

Keywords: Pseudomonas aeruginosa; cAMP; caspase-1; pulmonary endothelial cells; stress responses.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • 1-Methyl-3-isobutylxanthine / pharmacology
  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Adenine / analogs & derivatives
  • Adenine / pharmacology
  • Alprostadil / analogs & derivatives
  • Alprostadil / pharmacology
  • Animals
  • Caspase 1 / genetics*
  • Caspase 1 / metabolism
  • Cell Proliferation / drug effects
  • Colforsin / pharmacology
  • Cyclic AMP / agonists
  • Cyclic AMP / antagonists & inhibitors
  • Cyclic AMP / metabolism*
  • Cyclic GMP / analogs & derivatives
  • Cyclic GMP / pharmacology
  • Dinoprostone / pharmacology
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism*
  • Endothelial Cells / microbiology
  • Endothelial Cells / pathology
  • Gene Expression Regulation
  • Host-Pathogen Interactions / genetics
  • Inflammasomes / drug effects
  • Inflammasomes / genetics
  • Inflammasomes / metabolism
  • Interleukin-1beta / genetics
  • Interleukin-1beta / metabolism
  • Lung / metabolism
  • Lung / microbiology
  • Lung / pathology
  • Primary Cell Culture
  • Pseudomonas aeruginosa / drug effects
  • Pseudomonas aeruginosa / growth & development
  • Pseudomonas aeruginosa / metabolism*
  • Rats
  • Rolipram / pharmacology
  • Signal Transduction*
  • Single-Cell Analysis

Substances

  • IL1B protein, rat
  • Inflammasomes
  • Interleukin-1beta
  • 9-(tetrahydro-2-furyl)-adenine
  • Colforsin
  • 8-Bromo Cyclic Adenosine Monophosphate
  • 8-bromocyclic GMP
  • Cyclic AMP
  • Caspase 1
  • Alprostadil
  • Cyclic GMP
  • butaprost
  • Adenine
  • Rolipram
  • Dinoprostone
  • 1-Methyl-3-isobutylxanthine